Neuroone Medical Technologies is trading 5.09% down now at $2.05, with no clear August 26, 2026 company-specific announcement or market-wide selloff explaining the move.
- Latest identified developments were August 13 fiscal-third-quarter results and August 11 ISO 13485 certification.
- Earnings included a revenue miss and supply-capacity constraints, but those events predated today’s decline.
- Broader indexes were roughly flat before the open, weakening the case for a global catalyst.